LAGUNA BEACH, Calif.--(BUSINESS WIRE)--Cobalis Corporation (OTC:CLSC), a pharmaceutical and nutraceutical biotechnology company specializing in the development of anti-allergy medications announced today that they have completed a signed Letter of Intent (LOI) with International Shipping and Marketing LLC (ISM) to distribute and market PreHistin®. PreHistin® is Cobalis’ patented revolutionary allergy prevention product available for worldwide sales at www.PreHistin.com.
